2002
DOI: 10.1055/s-2002-19826
|View full text |Cite
|
Sign up to set email alerts
|

Growth Factor Therapy to Improve Soft Tissue Healing

Abstract: The advent of new U.S. Food and Drug Administration-approved products containing growth factors to improve soft tissue healing signifies a new era for wound healing. Over the last decade, some clinical growth factor studies have been promising, whereas others have not shown any positive effect. What many of these studies have shown is that the state of a healing wound is not only dependent on its growth factor milieu but also on other variables (wound care, tissue oxygen state, bacteria count, and nutritional … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
25
0
2

Year Published

2006
2006
2013
2013

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 53 publications
1
25
0
2
Order By: Relevance
“…Growth factor therapy is considered as a ''trigger'' to jump start biological mechanisms, 21 which may be the reason why only a single injection of bFGF solution made such drastic effects as seen in the present study. Further studies are necessary to clarify how long the effects last and how consistently it works for different patients.…”
Section: Discussionmentioning
confidence: 59%
“…Growth factor therapy is considered as a ''trigger'' to jump start biological mechanisms, 21 which may be the reason why only a single injection of bFGF solution made such drastic effects as seen in the present study. Further studies are necessary to clarify how long the effects last and how consistently it works for different patients.…”
Section: Discussionmentioning
confidence: 59%
“…One of the promising yet clinically challenging areas of recent therapeutic development involves topical application of growth factors to enhance the normal healing process. 1 Many of these new therapies have involved the provision of individual trophic factors with defined biological activities. They have a restricting growth factor release that is dependent on matrix loading, thus potentially limiting their overall ability to affect healing.…”
mentioning
confidence: 99%
“…The administration of several recombinant growth factors has shown clinical improvement in wound-healing rates in preclinical animal models (62)(63)(64)(65). In incisional wound healing, PDGF induces fibroblast proliferation and differentiation, collagen deposition and angiogenesis (66,67).…”
Section: Growth Factors In Preclinical Studiesmentioning
confidence: 99%